⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 30, 2024Endocrine Abstracts

Primary aldosteronism: small molecule antagonists of mutant KCNJ5 potassium channels

Sanas Mir-Bashiri Martina Tetti Dennis Fröbel D Reiss Mirko Peitzsch Nicole Bechmann Martín Reincke Williams Tracy Ann

View at Publisher

Ask AI

Bookmark

Share

Key Points

Mutant KCNJ5 channels were effectively targeted, leading to significant improvements in aldosteronism.
Key changes were observed in the function of potassium channels with small molecules, indicating high efficacy.
The analysis utilized an experimental approach with various small molecule antagonists to assess their effects on KCNJ5 activity and aldosteronism-related symptoms. Further exploration is necessary to confirm these findings across diverse clinical settings.

Implication

Demonstrates effects of small molecule antagonists on mutant KCNJ5 channels in aldosteronism, suggesting novel treatment options.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mir-Bashiri et al. (2024) studied this question.

synapsesocial.com/papers/68e5a4ccb6db64358753efa3 https://doi.org/10.1530/endoabs.102.22

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Primary aldosteronism: Small molecule antagonists of mutant KCNJ5 potassium channels2024
2Primary aldosteronism: insights from a single center cohort2024
3Primary aldosteronism in patient with autosomal dominant polycystic kidney diseases: diagnostic and therapeutic challenge2024
4Primary aldosteronism: clinical presentation and management about 2 cases2024
5Prevalence and significance of hypokalemia in primary aldosteronism: a retrospective study2024

More related papers

Modulation of calcium signaling on demand to decipher the molecular mechanisms of primary aldosteronism2024
Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism2024
Aldosterone:metanephrine ratio better predicts laterality in patients with primary aldosteronism and mild autonomous cortisol co-secretion than aldosterone:cortisol ratio2024

More from Endocrine Abstracts

The Need for a Global Registry for Charting the Natural History of Klinefelter SyndromeFri,
Impact of alert systems on glucocorticoid administration for adrenal insufficiency in the emergency departmentFri,